230 related articles for article (PubMed ID: 35615532)
1. ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma.
Sun Q; Liu X; Peng Q; Hu L; Jiang X
J Immunol Res; 2022; 2022():1584397. PubMed ID: 35615532
[TBL] [Abstract][Full Text] [Related]
2. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Li L; Wang X; Ding Y; Hui N; Su B; Yang M
Eur J Med Res; 2022 Oct; 27(1):216. PubMed ID: 36307879
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CARMN Affects Hepatocellular Carcinoma Prognosis by Regulating the miR-192-5p/LOXL2 Axis.
Wang X; Wu S; Yang Y; Zhao J
Oxid Med Cell Longev; 2022; 2022():9277360. PubMed ID: 36254230
[TBL] [Abstract][Full Text] [Related]
4. COMMD2 Upregulation Mediated by an ncRNA Axis Correlates With an Unfavorable Prognosis and Tumor Immune Infiltration in Liver Hepatocellular Carcinoma.
Fang W; Gan Y; Zhang L; Xiong J
Front Oncol; 2022; 12():853026. PubMed ID: 35574298
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.
Wu S; Liu S; Cao Y; Chao G; Wang P; Pan H
Aging (Albany NY); 2022 Mar; 14(5):2304-2319. PubMed ID: 35278064
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of LPCAT1 Repressed Hepatocellular Carcinoma Growth and Invasion by Targeting S100A11.
Sun Q; Fu C; Liu J; Li S; Zheng J
Ann Clin Lab Sci; 2023 Mar; 53(2):212-221. PubMed ID: 37094849
[TBL] [Abstract][Full Text] [Related]
7. Genomic gain/methylation modification/hsa-miR-132-3p increases RRS1 overexpression in liver hepatocellular carcinoma.
Zhang X; Cong P; Tian L; Zheng Y; Zhang H; Liu Q; Wu T; Zhang Q; Wu H; Huang X; Xiong L
Cancer Sci; 2023 Nov; 114(11):4329-4342. PubMed ID: 37705317
[TBL] [Abstract][Full Text] [Related]
8. High expression of RNF31 is associated with tumor immune cell infiltration and leads to poor prognosis in liver hepatocellular carcinoma.
Xi G; Cheng R; Liang L; Che N; Wang Y; Zhao N; Liang X; Shao B; Zhao X; Zhang D
Sci Rep; 2023 Apr; 13(1):6957. PubMed ID: 37117215
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma.
Lin YR; Yang WJ; Yang GW
Aging (Albany NY); 2021 May; 13(9):12929-12954. PubMed ID: 33952716
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis to identify noncoding RNAs mediated upregulation of maternal embryonic leucine zipper kinase (MELK) correlated with poor prognosis in hepatocellular carcinoma.
Guo Z; Zhu Z
Aging (Albany NY); 2022 May; 14(9):3973-3988. PubMed ID: 35511171
[TBL] [Abstract][Full Text] [Related]
11. Type-1 Na
Zhou YT; Chen H; Ai M; Li SS; Li BY; Zhao Y; Cai WW; Hou B; Ni LL; Xu F; Qiu LY
Life Sci; 2021 Aug; 278():119613. PubMed ID: 34000263
[TBL] [Abstract][Full Text] [Related]
12. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
[TBL] [Abstract][Full Text] [Related]
13. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
[TBL] [Abstract][Full Text] [Related]
14. A miR-205-LPCAT1 axis contributes to proliferation and progression in multiple cancers.
Liu F; Wu Y; Liu J; Ni RJ; Yang AG; Bian K; Zhang R
Biochem Biophys Res Commun; 2020 Jun; 527(2):474-480. PubMed ID: 32334831
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of MAD2L1 mediated by ncRNA axis is associated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma: A review.
Liu S; Miao M; Kang L
Medicine (Baltimore); 2023 Jan; 102(2):e32625. PubMed ID: 36637946
[TBL] [Abstract][Full Text] [Related]
16. LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression.
Wang B; Chen L; Li Q; Zhou J; Jin W
Transl Cancer Res; 2023 May; 12(5):1290-1306. PubMed ID: 37304553
[TBL] [Abstract][Full Text] [Related]
17. ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.
Lou W; Wang W; Chen J; Wang S; Huang Y
Mol Ther Nucleic Acids; 2021 Jun; 24():845-855. PubMed ID: 34026328
[TBL] [Abstract][Full Text] [Related]
18. PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.
Jin W; Wang G; Dong M; Wang X
Eur J Med Res; 2024 Mar; 29(1):177. PubMed ID: 38494503
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of N
Zhu HX; Lu WJ; Zhu WP; Yu S
J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346
[TBL] [Abstract][Full Text] [Related]
20. ncRNA-Regulated LAYN Serves as a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Cao L; Zhu L; Cheng L
Biomed Res Int; 2022; 2022():5357114. PubMed ID: 36398067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
